Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Matthew M. Lowe
Don’t wait until something bad happens to make a change
Kari Miller
A lack of integration hampers quality compliance across a product’s life cycle
Etienne Nichols
A well-defined CAPA program is a framework for quality and effectiveness
Grant Ramaley
IAF CertSearch now mandatory for accredited certification bodies
Etienne Nichols
What’s the difference?

More Features

FDA Compliance News
Creates one of the most comprehensive regulatory SaaS platforms for the industry
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community

More News

Quality Digest

FDA Compliance

BioMed Realty Trust Acquires Two New Properties

Published: Wednesday, October 26, 2005 - 22:00

BioMed Realty Trust Inc. recently acquired two new properties, one in San Diego and one in the San Francisco area.The company’s new site in San Diego is it ninth in that area. It purchased the 28,704 square-foot facility for $8.5 million from Isis Pharmaceuticals Inc. Isis, a public biopharmaceutical company that exploits RNA-based drug discovery technologies, has entered into a 15-year lease on the property. The San Francisco-area property contains 88,000 rentable square feet, which is currently under redevelopment. It is BioMed Realty Trust’s sixth San Francisco-area property.

The acquisitions increase the company’s real estate portfolio to 35 properties, representing 58 buildings with approximately 4.4 million rentable square feet. The company focuses on acquiring, owning, developing, leasing and managing laboratory and office space for the life sciences and pharmaceutical industries.

“The acquisitions in San Diego and San Francisco further strengthen the company’s presence in these important life-science markets,” says Alan D. Gold, BioMed Realty Trust president and CEO. “They reflect BioMed’s commitment to our corporate mission of providing real estate to the life-science industry.”

For more information, visit www.biomedrealty.com.


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.